XML 49 R35.htm IDEA: XBRL DOCUMENT v3.5.0.2
EMPLOYEE STOCK PLANS (Tables)
9 Months Ended
Jul. 01, 2016
Disclosure of Compensation Related Costs, Share-based Payments [Abstract]  
Net Share-Based Compensation Expense
The table below summarizes the net share-based compensation expense recognized for employee stock awards and for the option component of the employee stock purchase plan shares:
 
Three Months Ended
 
Nine Months Ended
(In thousands)
July 1,
2016
 
July 3,
2015
 
July 1,
2016
 
July 3,
2015
Cost of revenues - Product
$
1,033

 
$
1,263

 
$
3,141

 
$
3,578

Cost of revenues - Service
1,114

 
1,066

 
3,063

 
3,004

Research and development
1,723

 
1,717

 
5,046

 
5,109

Selling, general and administrative
8,346

 
7,310

 
24,771

 
24,903

Total share-based compensation expense
$
12,216

 
$
11,356

 
$
36,021

 
$
36,594

Income tax benefit for share-based compensation
$
(3,701
)
 
$
(3,455
)
 
$
(10,958
)
 
$
(11,371
)
Fair Value of Employee Stock Option Plans With Weighted Average Assumptions
The fair value of options granted was estimated at the date of grant using the Black-Scholes model with the following weighted average assumptions: 
 
Three Months Ended
 
Nine Months Ended
 
July 1,
2016
 
July 3,
2015
 
July 1,
2016
 
July 3,
2015
Employee Stock Option Plans
 
 
 
 
 
 
 
Expected term (in years)
4.13

 
4.13

 
4.13

 
4.15

Risk-free interest rate
1.2
%
 
1.3
%
 
1.1
%
 
1.3
%
Expected volatility
20.5
%
 
21.6
%
 
20.1
%
 
22.1
%
Expected dividend
%
 
%
 
%
 
%
Weighted average fair value at grant date
$
15.29

 
$
17.16

 
$
13.71

 
$
18.52

Fair Value of Employee Stock Purchase Plan With Weighted Average Assumptions
The option component of employee stock purchase plan shares was estimated at the date of grant using the Black-Scholes model with the following weighted average assumptions: 
 
Three Months Ended
 
Nine Months Ended
 
July 1,
2016
 
July 3,
2015
 
July 1,
2016
 
July 3,
2015
Employee Stock Purchase Plan
 
 
 
 
 
 
 
Expected term (in years)
0.50

 
0.50

 
0.50

 
0.50

Risk-free interest rate
0.4
%
 
0.1
%
 
0.3
%
 
0.1
%
Expected volatility
18.3
%
 
17.2
%
 
17.6
%
 
12.7
%
Expected dividend
%
 
%
 
%
 
%
Weighted average fair value at grant date
$
16.60

 
$
17.56

 
$
16.09

 
$
15.87

Summary of Share-Based Awards Available for Grant
A summary of share-based awards available for grant is as follows:
(In thousands)
Shares Available for Grant
Balance at October 2, 2015
6,661

Granted
(2,327
)
Cancelled or expired
277

Balance at July 1, 2016
4,611

Activity Under Employee Stock Plans
Activity under the Company’s employee stock plans is presented below: 
 
Options Outstanding
(In thousands, except per share amounts)
Number of
Shares
 
Weighted
Average
Exercise
Price
 
Weighted
Average
Remaining
Term (in years)
 
Aggregate
Intrinsic
Value (1)
Balance at October 2, 2015
2,537

 
$
72.58

 
 
 
 
Granted
828

 
75.97

 
 
 
 
Cancelled or expired
(23
)
 
85.95

 
 
 
 
Exercised
(377
)
 
52.02

 
 
 
 
Balance at July 1, 2016
2,965

 
$
76.03

 
4.6
 
$
26,060

 
 
 
 
 
 
 
 
Exercisable at July 1, 2016
1,664

 
$
72.13

 
3.4
 
$
20,556



(1)
The aggregate intrinsic value represents the total pre-tax intrinsic value of options, which is computed based on the difference between the exercise price and VMS’s closing common stock price of $82.60 as of July 1, 2016, the last trading date of the third quarter of fiscal year 2016, and which would have been received by the option holders had all option holders exercised and sold their options as of that date.
Activity for Restricted Stock, Restricted Stock Units, Deferred Stock Units and Performance Units
The activity for restricted stock, restricted stock units, deferred stock units and performance units is summarized as follows:
(In thousands, except per share amounts)
Number of
Shares
 
Weighted Average
Grant-Date Fair
Value
Balance at October 2, 2015
950

 
$
84.11

Granted
485

 
77.89

Vested
(389
)
 
80.98

Cancelled or expired
(75
)
 
81.86

Balance at April 1, 2016
971

 
$
82.36